Skip to main content
Top
Published in: Clinical Rheumatology 2/2008

01-02-2008 | Original Article

Characteristic electron microscopic findings in the skin of patients with fibromyalgia—preliminary study

Authors: Seong-Ho Kim, Dong Hoon Kim, Dong-Ho Oh, Daniel J. Clauw

Published in: Clinical Rheumatology | Issue 2/2008

Login to get access

Abstract

This blinded study was done to determine if there are any abnormal electron microscopic (EM) findings in the skin of fibromyalgia syndrome (FMS) patients, which might contribute to or be due to the increased pain sensitivity seen in this condition. Skin biopsy samples were obtained from 13 FMS patients and 5 control subjects. All tissues were prepared for EM examination by immediate prefixation in 2.5% glutaraldehyde for 2 h and postfixation in 1% osmium acid for 24 h. Ultrathin sections on grids were stained by uranyl acetate and lead citrate. Biopsies were read by an individual without knowledge of participant status. Five skin biopsies from healthy controls showed relatively even distribution of variegated sized unmyelinated axons sheathed well by complicatedly folded Schwann cell membranes. In tissues from 9/13 FMS patients, unmyelinated Schwann cells were noted to be ballooned, whereas this finding was not noted in any controls (p = 0.029). Axons in most patients trended towards being localized in the periphery of the unmyelinated Schwann cell sheaths (p = 0.002). Particularly, peripheral localization of axon in the unmyelinated Schwann cell sheath had a strong relationship with ballooning of Schwann cell (p = 0.042), simplified folding of Schwann cell sheath (p = 0.039) and smaller axon (p = 0.034). Myelinated nerve fibers were unremarkable. The EM findings seen in the skin of FMS patients show unusual patterns of unmyelinated nerve fibers as well as associated Schwann cells. If these findings are replicated in a larger study, these abnormalities may contribute to, or be due to, the lower pain threshold seen in FMS patients.
Literature
1.
go back to reference Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef
2.
go back to reference Clauw DJ (1995) The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia. Med Hypotheses 44:369–378PubMedCrossRef Clauw DJ (1995) The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia. Med Hypotheses 44:369–378PubMedCrossRef
3.
go back to reference Gracely RH, Petzke F, Wolf JM et al (2002) Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46(5):1333–1343PubMedCrossRef Gracely RH, Petzke F, Wolf JM et al (2002) Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46(5):1333–1343PubMedCrossRef
4.
go back to reference Juliena N, Goffauxb P, Arsenaultb P et al (2005) Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114:295–302CrossRef Juliena N, Goffauxb P, Arsenaultb P et al (2005) Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114:295–302CrossRef
5.
go back to reference Dadabhoy D, Clauw DJ (2005) Fibromyalgia: progress in diagnosis and treatment. Curr Pain Headache Rep 9(6):399–404PubMedCrossRef Dadabhoy D, Clauw DJ (2005) Fibromyalgia: progress in diagnosis and treatment. Curr Pain Headache Rep 9(6):399–404PubMedCrossRef
6.
go back to reference Granges G, Littlejohn G (1993) Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 36:642–646PubMedCrossRef Granges G, Littlejohn G (1993) Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 36:642–646PubMedCrossRef
7.
go back to reference Aaron LA, Burke MM, Buchwald D (2000) Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 160:221–227PubMedCrossRef Aaron LA, Burke MM, Buchwald D (2000) Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 160:221–227PubMedCrossRef
8.
go back to reference Simms RW (1996) Is there muscle pathology in fibromyalgia syndrome? Rheum Dis Clin North Am 22:245–266PubMedCrossRef Simms RW (1996) Is there muscle pathology in fibromyalgia syndrome? Rheum Dis Clin North Am 22:245–266PubMedCrossRef
9.
go back to reference Sprott H, Salemi S, Gay RE et al (2004) Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann Rheum Dis 63(3):245–251PubMedCrossRef Sprott H, Salemi S, Gay RE et al (2004) Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann Rheum Dis 63(3):245–251PubMedCrossRef
10.
go back to reference Kim SH, Jang TJ, Moon IS (2006) Increased expression of N-Methyl-d-Aspartate Receptor Subunit 2D in the skin of patients with fibromyalgia. J Rheumatol 33:785–788PubMed Kim SH, Jang TJ, Moon IS (2006) Increased expression of N-Methyl-d-Aspartate Receptor Subunit 2D in the skin of patients with fibromyalgia. J Rheumatol 33:785–788PubMed
11.
go back to reference Ribel-Madsen S, Gronemann ST, Bartels EM et al (2005) Collagen structure in skin from fibromyalgia patients. Int J Tissue React 27(3):75–82PubMed Ribel-Madsen S, Gronemann ST, Bartels EM et al (2005) Collagen structure in skin from fibromyalgia patients. Int J Tissue React 27(3):75–82PubMed
12.
go back to reference Littlejohn GO, Weinstein C, Helme RD (1987) Increased neurogenic inflammation in fibrositis syndrome. J Rheumatol 14(5):1022–1025PubMed Littlejohn GO, Weinstein C, Helme RD (1987) Increased neurogenic inflammation in fibrositis syndrome. J Rheumatol 14(5):1022–1025PubMed
13.
go back to reference Enestrom S, Bengtsson A, Frodin T (1997) Dermal IgG deposits and increase of mast cells in patients with fibromyalgia—relevant findings or epiphenomena? Scand J Rheumatol 26(4):308–313PubMedCrossRef Enestrom S, Bengtsson A, Frodin T (1997) Dermal IgG deposits and increase of mast cells in patients with fibromyalgia—relevant findings or epiphenomena? Scand J Rheumatol 26(4):308–313PubMedCrossRef
14.
go back to reference Salemi S, Rethage J, Wollina U et al (2003) Detection of interleukin 1ß (IL-1ß), IL-6, and tumor necrosis factor-α in skin of patients with fibromyalgia. J Rheumatol 30:146–150PubMed Salemi S, Rethage J, Wollina U et al (2003) Detection of interleukin 1ß (IL-1ß), IL-6, and tumor necrosis factor-α in skin of patients with fibromyalgia. J Rheumatol 30:146–150PubMed
15.
go back to reference Sprott H, Muller A, Heine H (1997) Collagen crosslinks in fibromyalgia. Arthritis Rheum 40(8):1450–1454PubMedCrossRef Sprott H, Muller A, Heine H (1997) Collagen crosslinks in fibromyalgia. Arthritis Rheum 40(8):1450–1454PubMedCrossRef
16.
go back to reference Lauria G, Morbin M, Lombardi R et al (2003) Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 61:631–636PubMed Lauria G, Morbin M, Lombardi R et al (2003) Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 61:631–636PubMed
Metadata
Title
Characteristic electron microscopic findings in the skin of patients with fibromyalgia—preliminary study
Authors
Seong-Ho Kim
Dong Hoon Kim
Dong-Ho Oh
Daniel J. Clauw
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0739-2

Other articles of this Issue 2/2008

Clinical Rheumatology 2/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.